Mindmed to participate in the jefferies london healthcare conference

New york , nov. 11, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of the company's management team will participate in the jefferies london healthcare conference, taking place in london, uk from november 15-17, 2022. jefferies london healthcare conference format: presentation and one-on-one investor meetingspresentation date: wednesday, november 16, 2022 presentation time: 3:50 p.m.
MNMD Ratings Summary
MNMD Quant Ranking